Intelligent Genomics.
Better
Tomorrow.
We are an oncology-focused healthcare solutions company dedicated to advancing cancer care through precision diagnostics, molecular oncology solutions, and innovative clinical technologies.
who we are
A healthcare solutions partner — bridging
global innovation with
Indian clinical practice.
IntelliGene Healthcare connects world-class oncology technologies, advanced medical equipment, and international-standard medicines from leading global and Indian partners with the everyday needs of clinicians, hospitals, and patients across India.
OUR SOLUTIONS
Three focused categories.
One unified standard.
We bring together best-in-class partners across diagnostics, Indian medicine, and international medicine — so oncology programs in India can access the same caliber of innovation available anywhere in the world.
why intelligene
Where global innovation meets
everyday clinical practice.
World-class partners
Direct access to advanced diagnostic platforms, equipment, and oncology therapeutics from leading global and Indian partners.
Genomics-driven insights
Every solution we curate is built on validated genomic intelligence — turning complex molecular data into clinical clarity.
End-to-end support
Sample logistics, integration, training, and molecular tumor board access — we walk alongside every oncology program.
Built for the hospitals
Workflows, pricing, and supply chain designed for Indian hospital pharmacies, cancer centers, and clinician teams.
We work with carefully selected diagnostic innovators so Indian oncology programs get access to the same caliber of molecular testing available at the world's leading cancer centers.
featured prdoucts
Comprehensive Products.
Delivered with global standards.
international partner
Genomate
AI-powered Targeted Drug Therapy for Cancer Patients
-
AI-powered therapy ranking across complex tumor mutations
-
Comprehensive genomic profiling with actionable treatment insights
-
Liquid biopsy and tissue-based molecular interpretation support
-
Clinical decision support validated in international oncology studies
-
Expert-reviewed reports with precision therapy recommendations
-
EMR-ready reporting formats including PDF and interoperable workflows
351 Gene Panel
IntelliCore
Core Companion Diagnostic —FFPE Tissue & cfDNA Liquid Biopsy
-
351 clinically significant oncogenes
-
FFPE tissue (1000–3000x) & cfDNA liquid biopsy (up to 10,000x)
-
SNVs, Indels, CNAs, Fusions, TMB, MSI, HRR
-
Agilent SureSelect XT HS2 DNA capture
-
MSK OncoKB-annotated reporting
-
Pharmacogenomics (germline)
-
Ideal for: All solid tumors, standard CDx workup, liquid biopsy cases, tissue limited samples
651 Gene DNA + RNA Panel
IntelliFusion
Extended Genomic Profiling — High-Quality Tissue Only
-
651 genes including additional research & emerging biomarkers
-
Tissue sample only (FFPE) — not available for liquid biopsy
-
Requires high-quality RNA (RIN ≥4, DV200 ≥30%) for fusion detection via RNA-based capture
-
DNA + RNA dual capture for comprehensive fusion & splice variant coverage
-
Extended intronic regions for rare rearrangement partners
-
Broader CNA profiling across additional oncogenes & tumor suppressors
-
All 351-panel biomarkers included (TMB, MSI, HRR, PGx)
We carefully identify and bring together globally trusted oncology technologies and solutions, making them practical, accessible, and relevant for Indian clinical practice.
Intelligent Genomics. Better Tomorrow.